| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |